TY - JOUR T1 - Assessing liver fibrosis without biopsy in patients with HCV or NAFLD JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 179 LP - 186 DO - 10.3949/ccjm.86a.17118 VL - 86 IS - 3 AU - Tavankit Singh AU - Daniela S. Allende AU - Arthur J. McCullough Y1 - 2019/03/01 UR - http://www.ccjm.org/content/86/3/179.abstract N2 - Staging of liver fibrosis is increasingly done using noninvasive methods, in some cases obviating the need for liver biopsy. Scores based on laboratory values and demographic variables have been developed and validated for assessing fibrosis in patients with hepatitis C virus (HCV) infection and nonalcoholic fatty liver disease (NAFLD), as have several imaging methods that measure shear-wave velocity, a reflection of fibrosis severity. ER -